1. Introduction {#sec1-molecules-24-02784}
===============

*Pluchea indica* Less. belongs to the Asteraceae family, and is a kind of medicine and food dual-use plant which mainly distributes in the tropical and subtropical regions. As a kind of amphibious woody semi-mangrove plant, it not only survives in the intertidal zone and becomes a dominant species on the beach, but also naturally breeds in the terrestrial environment. *P. indica* plays a significant role in maintaining ecological balance of coastal areas in the southeast of Asia. Its outstanding effect in softening hardness and dissipating binds has been discovered and utilized by people of the Zhuang nationality in Guangxi for several decades \[[@B1-molecules-24-02784]\]. In vitro cytotoxicity test results indicated that the ethanol extract of *P. indica* leaf exhibited wound healing activity, owing to its ability to improve the cell viability of oral mucosal cell line and accelerate wound closure \[[@B2-molecules-24-02784]\], which suggested that *P. indica* has no toxicity. Next, *P. indica* is not only one of the most famous food ingredients in China \[[@B3-molecules-24-02784]\] but also used as a table salad in Malaysia \[[@B4-molecules-24-02784]\].

Meanwhile, it was also reported that *P. indica* ethanol extract possessed significant inhibitory effects on not only adipocytes lipids and carbohydrate accumulation but also pancreatic lipase activity, which provided evidence for its antiobesity activity \[[@B5-molecules-24-02784]\]. Chemical investigation results suggested the main constituents in this plant are quinic acids, thiophenes, flavonoids, and other phenolic acids \[[@B6-molecules-24-02784],[@B7-molecules-24-02784],[@B8-molecules-24-02784]\]. Among them, quinic acids are the most common dietary polyphenolic compounds, which are widely found in tea, coffee and other foods. It has been reported to exhibit multiple bioactivities such as anti-inflammation and hepatoprotection \[[@B4-molecules-24-02784]\]. What is more, owing to its high content of phenolic compounds, its free radical scavenging activity has been investigated and certified yet, which suggested that *P. indica* displayed antioxidation effect \[[@B9-molecules-24-02784],[@B10-molecules-24-02784]\]. Various thiophenes have been considered to be "generally recognized as safe" (GRAS) by the Flavor and Extract Manufacturers Association (FEMA), and re-evaluated to be safe as a kind of food flavor ingredient according to scientific data \[[@B11-molecules-24-02784]\]. What is more, the usage of the phenolic acids in dietary has also been popularized all over the world \[[@B12-molecules-24-02784]\].

The application of *P. indica* in food additives is more and more extensive. However, during the chemical researches in our lab, we found a large amount of pigment existed in the plant made it difficult to accomplish the comprehensive characterization of chemical composition. Meanwhile, the analysis directly acomplished by LC-MS usually limited the characterization fewer than 50 compounds \[[@B13-molecules-24-02784],[@B14-molecules-24-02784]\]. A strategy that could improve the chromatographic peak capacity should be considered \[[@B15-molecules-24-02784]\]. As we known, the constituents in *P. Indica* are varieties, and ideal separation effect is often hardly obtained by conventional reversed-phase chromatography \[[@B16-molecules-24-02784]\]. Then, preliminary fractionation for its crude extracts by normal-phase silica gel column was utilized before reversed-phase chromatography analysis.

According to our previous study \[[@B7-molecules-24-02784],[@B8-molecules-24-02784]\], the main constituents in *P. indica* are known to be quinic acids, flavonoids, thiophenes, phenolic acids, and sesquiterpenes. And in the process of LC-MS analysis, we found that in the negative ion mode, fragments from \[M -- H\]^--^ ions could provide more comprehensive information for quinic acids, flavonoids, and phenolic acids, while thiophenes and sesquiterpenes were more inclined to be detected by positive ion mode. Thus, in this study, the ESI-Q-Orbitrap MS was used as the detector in both positive and negative ion modes.

This paper aimed to use a LC-MS analysis method by an orthogonal chromatography (OC) integrating reversed-phase chromatography BEHC18 column with normal-phase chromatography silica column to achieve the characterization and identification of *P. indica* comprehensively. Six fractions of 95% eluates of the aerial parts of *P. indica* (PIE1--PIE6) were subsequently analyzed by LC-MS on an ESI-Q-Orbitrap MS in both negative and positive ion modes. According to the retention time (*t~R~*) and the exact mass-to-charge ratio (*m*/*z*), 67 compounds were unambiguously identified by comparing to the standard references. Meanwhile, the rules of MS/MS fragmentation pattern and chromatographic elution order have been generalized by using the reference standards, 47 compounds were tentatively speculated, and 10 of them were potential new ones.

2. Experimental {#sec2-molecules-24-02784}
===============

2.1. Materials {#sec2dot1-molecules-24-02784}
--------------

The aerial parts of *P. indica* were collected from Hepu City, Guangxi Province, China, and identified by Dr. Songji Wei (Zhuang Medical College of Guangxi University of Chinese Medicine, Nanning, China). The voucher specimen was deposited at the institute of traditional Chinese Medicine of Tianjin University of TCM.

Sixty-seven compounds, including 20 quinic acids ([Figure S1](#app1-molecules-24-02784){ref-type="app"}), 19 phenolic acids ([Figure S2](#app1-molecules-24-02784){ref-type="app"}), 4 thiophenes ([Figure S3](#app1-molecules-24-02784){ref-type="app"}), 13 flavonoids ([Figure S4](#app1-molecules-24-02784){ref-type="app"}), and 11 others ([Figure S5](#app1-molecules-24-02784){ref-type="app"}), were used for reference standards. Their purities were \>98%. Among them, 60 (listed following) were prepared by ourselves, and 7 were purchased.

Among the 20 quinic acids, neochlorogenic acid (5-caffeoylquinic acid), methyl 3-*O*-caffeoyl quinate, and 1,5-di-*O*-caffeoyl quinic acid were purchased from Must Company (Chengdu, China); and 17 of them, chlorogenic acid (3-caffeoylquinic acid), 4-caffeoylquinic acid, 1,3-di-*O*-caffeoyl quinic acid, 1,4-di-*O-*caffeoyl quinic acid, 3,4-di-*O*-caffeoyl quinic acid, 3,5-di-*O*-caffeoyl quinic acid, 4,5-di-*O*-caffeoyl quinic acid, methyl 3,4-di-*O*-caffeoyl quinate, methyl 3,5-di-*O*-caffeoyl quinate, methyl 4,5-di-*O*-caffeoyl quinate, ethyl 3,4-di-*O*-caffeoyl quinate, ethyl 3,5-di-*O*-caffeoyl quinate, 1,3,4-tri-*O*-caffeoyl quinic acid, 1,3,5-tri-*O*-caffeoyl quinic acid, 3,4,5-tri-*O*-caffeoyl quinic acid, methyl 3,4,5-tri-*O*-caffeoyl quinate, and 1,3,4,5-tetra-*O*-caffeoyl quinic acid were isolated from the aerial parts of *P. indica* and *Chrysanthemum morifolium* \[[@B17-molecules-24-02784]\].

The phenolic acids, 3,4-dihydroxy benzoic acid, 3-methoxy-4-hydroxybenzoic acid, *p*-hydroxybenzoic acid, and *trans*-ferulic acid were purchased from Must Company (Chengdu, China). Other 15 ones, 3,4-dihydroxy benzaldehyde, vanillin, 3,4-dihydroxy-5-methoxybenzaldehyde, syringicaldehyde, dibutylphthalate, ethyl caffeate, 2,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)-propan-1-one, *trans*-coniferyl aldehyde, esculetin, *threo*-2,3-bis(4-hydroxy-3-methoxyphenyl)-3-ethoxypropan-1-ol, *erythro*-2,3-bis-(4-hydroxy-3-methoxyphenyl)-3-ethoxypropan-1-ol, (+)-isolariciresinol, (--)-(7*S*,7\'*S*,8*R*,8\'*R*)-4,4\'-dihydroxy-3,3\',5,5\'-pentamethoxy-7,9\':7\',9-diepoxylignane, (+)-9\'-isovaleryllariciresinol, and *trans*-caffeic acid were obtained from the aerial parts of *P. indica* \[[@B7-molecules-24-02784]\], *C. morifolium* \[[@B18-molecules-24-02784]\], *D. hypoglauca*, and *L. japonicas*.

The thiophenes, (3\'\'*R*)-pluthiophenol, (3\'\'*R*)-pluthiophenol-4\'\'-acetate, 3\'\'-ethoxyl-(3\'\'*S*)-pluthiophenol, and 3\'\'-ethoxyl-(3\'\'*S*)-pluthiophenol-4\'\'-acetate ([Figure S3](#app1-molecules-24-02784){ref-type="app"}) were isolated from the aerial parts of *P. indica* \[[@B7-molecules-24-02784]\].

Thirteen flavonoids ([Figure S4](#app1-molecules-24-02784){ref-type="app"}) including quercetin, quercetin-3-*O*-β-[d]{.smallcaps}-glucopyranoside, quercetin-3-*O*-β-[d]{.smallcaps}-galactopyranoside, isorhamnetin, 5,6,4\'-trihydroxy-3,7-dimethoxyflavone, centaureidin, chrysosplenol C, casticin, cynaroside, luteolin, kaempferol 3-*O*-β-[d]{.smallcaps}-glucopyranoside (astragalin), 5,7,3\',4\'-tetrahydroxy-3-methoxyflavonol-3\'-*O*-β-[d]{.smallcaps}-glucopyranoside, and kaempferol were isolated from the aerial parts of *P. indica* \[[@B8-molecules-24-02784]\], *C. morifolium* \[[@B17-molecules-24-02784]\], and *L. leontopodioides* by us.

Eleven other compounds ([Figure S5](#app1-molecules-24-02784){ref-type="app"}), caryolane-1,9β-diol, (8*R*,9*R*)-isocaryolane-8,9-diol, clovane-2α,9β-diol, valenc-1(10)-ene-8,11-diol, fraxinellone, stigmasterol, methyl 10-oxoundecanoate, triethyl citrate, 9,12,13-trihydroxyoctadeca-10(*E*),15(*Z*)-dienoic acid, and pinellic acid together with adenosine were obtained from *P. indica* aerial parts \[[@B7-molecules-24-02784]\].

HPLC grade Acetonitrile (Thermo-fisher, Waltham, MA, USA) and ultrapure water prepared with a Milli-Q purification system (Merck Millipore, Darmstadt, Hesse-Darmstadt, Germany) were used for LC-MS analysis. Analytical-grade ethanol (EtOH), chloroform (CHCl~3~), and methanol (MeOH) (Haiguang Chemical Reagent Factory, Tianjin, China), as well as silica gel (48--75 µm, Haiyang Chemical Reagent Factory, Qingdao, China) were used for the preparation of *P. indica* 70% EtOH extract (PI) and silica gel fractionation of 95% EtOH eluate (PIEs) test solutions.

2.2. Sample Preparation {#sec2dot2-molecules-24-02784}
-----------------------

### 2.2.1. Preparation of Standard Solutions {#sec2dot2dot1-molecules-24-02784}

Standard test solutions of above mentioned standard references were prepared in MeOH at a final concentration of \~100 ng/mL. All stock solutions were stored at 4 °C in darkness and brought to room temperature before use.

### 2.2.2. Preparation of *P. indica* 70% EtOH Extract Test Solutions {#sec2dot2dot2-molecules-24-02784}

An aliquot of 100 g dried aerial parts of *P. indica* was extracted under reflux in 800, 600, and 600 mL 70% ethanol (*v*/*v*) for 3, 2, and 2 h, respectively. The combined extracts were filtered with 0.22 µm microporous membrane to obtained PI stock solutions. PI stock solutions were stored at 4 °C in darkness and brought to room temperature before use.

### 2.2.3. Preparation of Silica Gel Fractionation of 95% EtOH Eluate of *P. indica* Test Solutions {#sec2dot2dot3-molecules-24-02784}

The above-mentioned PI stock solutions were evaporated to dryness under reduced pressure to obtain PI extract (20.55 g). The PI extract was dissolved in 800 mL of water and separated by D101 macroporous adsorption resin column (H~2~O → 95% EtOH) to obtain H~2~O eluate (15.45 g) and 95% EtOH eluate (PIE, 5.0 g), respectively. PIE (5.0 g) were subjected to normal-phase silica gel (50.0 g) column (CHCl~3~-MeOH (100:1 → 100:5, *v*/*v*) → CHCl~3~-MeOH-H~2~O (10:3:1 → 7:3:1 → 6:4:1 → 5:5:1, *v*/*v*/*v*, lower layer) → MeOH), six fractions (PIE1--PIE6) were obtained. PIE1--PIE6 were evaporated to dryness under reduced pressure, and then dissolved with MeOH to get six test stock solutions at a final concentration of 10 mg/mL. PIEs stock solutions were stored at 4 °C in darkness and brought to room temperature before use.

2.3. UHPLC {#sec2dot3-molecules-24-02784}
----------

A Thermo UltiMate 3000 UHPLC instrument (Thermo, Waltham, MA, USA) equipped with a quaternary pump and an autosampler were used to accomplish the analysis. Samples were separated on a Waters ACQUITY UPLC® BEH C18 (2.1 × 100 mm, 1.7 μm, Milford, MA, USA) using a mobile phase composed of H~2~O (A) and CH~3~CN with 0.1% CH~3~COOH (B) in the following gradient program; 0--4 min, 1--4% B; 4--18 min, 4% B; 18--20 min, 4--13% B; 20--24 min, 13% B; 24--35 min, 13--15% B; 35--37 min, 15--24% B; 37--45 min, 24--30% B; 45--46 min, 30--55% B; 46--52 min, 55% B; 52--53 min, 55--95% B; 53--58 min, 95% B. An equilibration of 3 min was used between successive injections. The flow rate was 0.4 mL/min, and column temperature was 35 °C. An aliquot of 3 μL of each sample was injected for analysis.

2.4. ESI-Q-Orbitrap MS and Automatic Components Extraction {#sec2dot4-molecules-24-02784}
----------------------------------------------------------

For tandem mass spectrometry analysis, a Thermo ESI-Q-Orbitrap MS mass spectrometer was connected to the UltiMate 3000 UHPLC instrument via ESI interface. Ultrahigh purity nitrogen (N~2~) was used as the collision gas and the sheath/auxiliary gas. The ESI source parameters were set as follows: ion spray voltage 3.2 kV, capillary temperature 350 °C, ion source heater temperature 300 °C, sheath gas (N~2~) 40 arbitrary units, auxiliary gas (N~2~) 10 arbitrary units, and a normalized collision energy (NCE) of 35 V was used. The Orbitrap analyzer scanned the mass range from *m/z* 100 to 1500. Monitoring time was 0--58 min. Detection was obtained by full mass-dd mass mode. The MS data were recorded in both profile and centroid formats. Data recording and processing were performed using the Xcalibur 4.0 software (Thermo Fisher Scientific, Inc., Waltham, MA, USA). The accuracy error threshold was fixed at 5 ppm.

Software-aided, automatic background subtraction and components extraction techniques were used to generate a peak list containing all the components profiled from the aerial part of *P. indica*. Sieve v2.2 SP2 (Thermo Fisher Scientific) was used for the automatic components extraction: time range: 1--58 min; BP minimum count: 10,000; BP minimum scans: 5; Background SN: 3; MZ Step: 10; and Frame, \>1.

3. Results and Discussion {#sec3-molecules-24-02784}
=========================

OC-MS technology integrated the large peak capacity of OC with the high detected sensitivity of MS, which could accomplish more comprehensive chemical profiling. Through comparing the separation effects of four kinds of high performance liquid chromatography columns (HSS C18, T3, CSH FP, and BEH C18 columns) with different separation mechanisms for PI, BEH C18 column was found to have better separation ability for most of the peaks in PI ([Figure S6](#app1-molecules-24-02784){ref-type="app"}). Then, it was chosen to carry out the composition analysis of *P. indica*. The comprehensive and accurate chemical composition profiling of *P. indica* was further accomplished by the OC-MS combined normal-phase silica gel column with reverse-phase BEH C18 column ([Figure 1](#molecules-24-02784-f001){ref-type="fig"} and [Figure 2](#molecules-24-02784-f002){ref-type="fig"}). As a result, the peak capacity and detection sensitivity were improved significantly, which is discussed in detail as follows.

3.1. Superiority of OC-MS than Directly LC-MS in the Chemical Composition Profiling of P. indica 70% EtOH Extract {#sec3dot1-molecules-24-02784}
-----------------------------------------------------------------------------------------------------------------

### 3.1.1. Increasing of the Peak Capacity by OC-MS Determination {#sec3dot1dot1-molecules-24-02784}

OC-MS, combing the advantages of the large peak capacity of OC and high sensitivity of mass spectrometry, had a wide range of applications, especially in the systematic chemical composition characterization of Traditional Chinese Medicine \[[@B15-molecules-24-02784]\].

The sieve statistical results indicated that OC-MS possessed much more peaks than directly LC-MS (PI: 234 peaks detected; PIEs: 735 peaks detected).

Taking the ion peak at 40.13 min as an example, when extracting it from the total ion chromatogram of PI, only the ion at *m*/*z* 677.15147 corresponding to 3,4,5-tricaffeoyl quinic acid could be observed obviously ([Figure S7](#app1-molecules-24-02784){ref-type="app"}). However, two ion peaks of belonging to 3,5-dicaffeylquinine ethyl acetate (*m*/*z* 543.15136) and 3,4,5-tricaffeoylquinic acid (*m*/*z* 677.15126) ([Figure S8](#app1-molecules-24-02784){ref-type="app"}) were extracted from the ion peak at 40.13 min of PIE4. And both of them appeared with extremely strong intensity. This result suggested that OC-MS technique could increase peak capacity of the chromatography greatly.

### 3.1.2. Increasing of the Detection Sensitivity by OC-MS Determination {#sec3dot1dot2-molecules-24-02784}

Ion peaks of *m/z* 677.15119 were extracted from the total ion chromatogram of PI and PIE6 ([Figure S9](#app1-molecules-24-02784){ref-type="app"}). It was found that the peak area ratios of 1,3,5-tricaffeoyl quinic acid (36.63 min), 1,3,4-tricaffeoylquinic acid (38.13 min), and 1,4,5-tricaffeoylquinic acid (39.86 min) to 3,4,5-tricaffeoylquinic acid (40.11 min) in PIE5 (0.15, 0.11, and 0.09, respectively) were significantly higher than those in PI (0.03, 0.03, and 0.01, respectively). The above-mentioned results indicated that OC-MS technique could improve detection sensitivity.

3.2. Structural Elucidation of Compounds from Silica Gel Fractionation of 95% EtOH Eluate of P. indica by OC-MS {#sec3dot2-molecules-24-02784}
---------------------------------------------------------------------------------------------------------------

### 3.2.1. Structural Elucidation of Quinic Acids and Their Derivatives {#sec3dot2dot1-molecules-24-02784}

Quinic acids and their derivatives are one kind of the most characteristic components in Asteraceae family plants \[[@B19-molecules-24-02784],[@B20-molecules-24-02784],[@B21-molecules-24-02784]\]. There are four hydroxyl groups substituted at 1-, 3-, 4-, and 5-position, as well as one carboxyl at 1-position of quinic acid, respectively, which means that the quinic acids derivatives can be formed at any one of above mentioned position or functional group theoretically. In fact, 1-, 3-, 4-, and 5-hydroxyl can dehydrate with caffeic acid, ferulic acid, coumaric acid, and 3,4,5-trihydroxycinnamic acid to form acyl-substituted quinic acids. What is more, the 1-carboxyl is easily to form methyl and ethyl esters.

#### Structural Elucidation of Mono-acyl Substituted Quinic Acids and Their Derivatives

Peaks **4** (*m/z* 353.08710 \[M − H\]^--^), **11** (*m/z* 353.08716 \[M -- H\]^--^), and **16** (*m/z* 353.08699 \[M -- H\]^--^) were unambiguously confirmed to be 5-caffeoylquinic acid (5-CQA), 3-CQA, and 4-CQA, respectively, by comparing to the standard references obtained from *C. morifolium* \[[@B17-molecules-24-02784]\]. As a result, the general MS/MS cleavage pattern of CQAs was summarized, which mainly included ester bond cleavage between caffeoyl and quinic acid groups, quinic acid dehydration, along with caffeoyl decarbonylation. Then, characteristic fragment ions at *m/z* 179.03389 \[caffeoyl − H\]^−^, 161.02332 \[caffeoyl -- H − H~2~O\]^−^, 135.04406 \[caffeoyl -- H − CO~2~\]^−^, 133.02841 \[caffeoyl -- H − H~2~O − CO\]^−^ for caffeoyl group and *m/z* 191.05501 \[quinic acid − H\]^−^, 173.04445 \[quinic acid -- H − H~2~O\]^−^ for quinic acid group were displayed in their mass spectra ([Figure 3](#molecules-24-02784-f003){ref-type="fig"}).

Comparing the MS/MS fragmentation characteristics and relative ion abundance of CQAs, it was found that the fragment ion type and ion intensity had a great correlation with the substitution position of caffeoyl group: in the MS/MS spectrum for 3-CQA, the characteristic fragment ion at *m/z* 191.05501 derived from quinic acid aglycone was the base peak; however, the ion peaks at *m/z* 179.03389, 161.02332, 135.04406, and 133.02841 for caffeoyl group and *m/z* 173.04445 for quinic acid group were very weak; in the MS/MS spectrum for 4-CQA, the ion peaks at *m/z* 191.05501 and 173.04445 for quinic acid group and 179.03389 and 135.04406 for caffeoyl group were stronger, and the base peak was *m/z* 173.04445 from quinic acid aglycone; meanwhile, in the MS/MS spectrum for 5-CQA, not only the characteristic fragment ions of *m/z* 191.05501 for quinic acid nucleus existed as base peak, but also the strong caffeoyl characterization fragment ions at *m/z* 179.03389 and 135.04406 displayed ([Figure S10](#app1-molecules-24-02784){ref-type="app"}). This phenomenon has also been observed in the study of chlorogenic acids in Kuding Tea \[[@B22-molecules-24-02784]\]. This feature might be caused by the axial conformation of 5-caffeoyl group, which made it easy for the cleavage of 5-caffeoyl group from the quinic acid nucleus to form relative stable fragmentation ions of both quinic acid and caffeoyl group.

Moreover, the chromatographic elution order \[retention time (*t*~R~)\] of CQAs in the CH~3~CN-H~2~O system was denoted as 5-CQA (peak **4**, *t*~R~ 4.97 min) \< 3-CQA (peak **11**, *t*~R~ 8.20 min) \< 4-CQA (peak **16**, *t*~R~ 10.69 min).

According to the reference \[[@B23-molecules-24-02784]\], the substituted group of quinic acid aglycone could also be feruloyl, and coumaroyl except for caffeoyl; mono-feruloyl quinic acid (FQAs) and mono-coumaroyl quinic acid (CoQAs) were also formed. Moreover, the possibility of 3,4,5-trihydroxycinnamoyl substitution (another kind of caffeoyl derivatives) has also been considered, which could form mono-3,4,5-trihydroxycinnamoyl quinic acid (TQAs). The characteristic ions of caffeoyl, feruloyl, coumaroyl, and 3,4,5-trihydroxycinnamoyl were considered to be at *m/z* 179.03389 (\[caffeoyl − H\]^−^), 193.04954 (\[feruloyl − H\]^−^), 163.03897 (\[coumaroyl − H\]^−^), and 195.02880 (\[3,4,5-trihydroxycinnamoyl − H\]^−^), respectively, which could be used to distinguish the type of substituted group.

In the MS/MS fragmentation spectra of peaks **3** (*m/z* 369.08246 \[M -- H\]^--^), **9** (*m/z* 369.08266 \[M -- H\]^--^), and **15** (*m/z* 369.08233 \[M -- H\]^--^) ([Figure S11](#app1-molecules-24-02784){ref-type="app"}), there were noticeable *m/z* 195.02880 (C~9~H~7~O~5~^−^) ions, which indicated that they were substituted by 3,4,5-trihydroxycinnamoyl group. The base peak of the MS/MS fragmentation spectra for peaks **3**, **9**, and **15** was *m/z* 191.05483, 133.02803, and 173.04421, respectively, and there were relatively strong ion at *m/z* 133.02803 in that of peak **3**. Thus, based on the above rules of MS/MS cleavage patterns and chromatographic elution order generalized by 5-CQA (peak **4**), 3-CQA (peak **11**), and 4-CQA (peak **16**), they were tentatively deduced to be 5-TQA (peak **3**), 3-TQA (peak **9**), and 4-TQA (peak **15**), respectively. They were all possible new ones. Using the same method, peaks **18** (*m/z* 337.09254 \[M -- H\]^--^) and **20** (*m/z* 337.09268 \[M -- H\]^--^) were tentatively identified as 3-CoQA and 4-CoQA, respectively ([Figure S12](#app1-molecules-24-02784){ref-type="app"}).

Peak **29** (*m/z* 367.10270 \[M -- H\]^--^) was unambiguously identified as 3-CQM by comparing with reference standard. Though the molecular of peaks **21** (*m/z* 367.10266 \[M -- H\]^--^), **22** (*m/z* 367.10208 \[M -- H\]^--^), **24** (*m/z* 367.10254 \[M -- H\]^--^), and **28** (*m/z* 367.10260 \[M -- H\]^--^) were similar with that of peak **29**; the appearance of *m/z* 193.04967 \[feruoyl − H\]^−^, 193.04965 \[feruoyl − H\]^−^ and 193.04939 \[feruoyl − H\]^−^ in the MS/MS spectra of peaks **21**, **22**, and **24**, respectively, indicated that these three compounds were substituted by feruoyl group. According to the chromatographic elution order summarized above, peaks **21**, **22**, and **24** were tentatively identified as 5-FQA, 3-FQA, and 4-FQA, respectively. In the MS/MS spectrum of peak **28**, the ions at *m/z* 193.04954 \[feruoyl − H\]^−^ was absent, while *m/z* 179.03380 \[caffeoyl − H\]^−^, 161.02313 \[caffeoyl -- H − H~2~O\]^−^ appeared, then it was deduced to be CQM. According to the chromatographic elution order of CQAs (*t*~R~: 5-CQA \< 3-CQA \< 4-CQA), and combining the occurrence probability of 1-CQM and 5-CQM, peak **28** was tentatively deduced to be 5-CQM. And it was found to be a new compound ([Figure S13](#app1-molecules-24-02784){ref-type="app"}).

#### Structural Elucidation of Multi-acyl Substituted Quinic Acids and Their Derivatives

Peaks **35** (*m/z* 515.11761 \[M -- H\]^--^), **37** (*m/z* 515.11694 \[M -- H\]^--^), **38** (*m/z* 515.11797 \[M -- H\]^--^), **39** (*m/z* 515.11713 \[M -- H\]^--^), **40** (*m/z* 515.11950 \[M -- H\]^--^), and **45** (*m/z* 515.11523 \[M -- H\]^--^) were definitively identified as 1,4-dicaffeoylquinic acid (1,4-diCQA), 1,5-diCQA, 1,3-diCQA, 4,5-diCQA, 3,5-diCQA, and 3,4-diCQA, respectively, by comparing to the standard references obtained from *C. morifolium* and *P. indica*. According to the MS/MS spectra of the six diCQAs, the general MS/MS fragmentation pattern diCQAs was summed up as following: the ion peak at *m/z* 173.04434 \[M -- H -- 2C~9~H~6~O~3~ -- H~2~O\]^--^, 173.04420 \[M -- H -- 2C~9~H~6~O~3~ -- H~2~O\]^--^, and 173.04430 \[M -- H -- 2C~9~H~6~O~3~ -- H~2~O\]^--^ derived from quinic acid aglycone was found to be the base peak in the MS/MS spectra of **35** (1,4-diCQA), **39** (4,5-diCQA), and **45** (3,4-diCQA), respectively ([Figure S14](#app1-molecules-24-02784){ref-type="app"}); the base peak of **37** (1,5-diCQA) was *m/z* 135.04356 \[M -- H -- C~9~H~6~O~3~ -- C~7~H~10~O~5~ -- CO~2~\]^--^ for caffeoyl group ([Figure S14](#app1-molecules-24-02784){ref-type="app"}); however, for **38** (1,3-diCQA) and **40** (3,5-diCQA), *m/z* 191.05495 \[M -- H -- 2C~9~H~6~O~3~\]^--^ and 191.05480 \[M -- H -- 2C~9~H~6~O~3~\]^--^ derived from quinic acid aglycone was the base peak, respectively ([Figure S14](#app1-molecules-24-02784){ref-type="app"}). The above mentioned rules was similar to those of CQAs, which suggested that when C-4 was substituted by caffeoyl (**35**, **39**, **45**), *m/z* 173.04445 was an indicator ion as its strong intensity ([Figure S14](#app1-molecules-24-02784){ref-type="app"}).

In addition, the chromatographic elution order of diCQAs in the CH~3~CN-H~2~O system was showed as 1,4-diCQA (peak **35**, *t*~R~ 27.11 min) \< 1,5-diCQA (peak **37**, *t*~R~ 27.99 min) \< 1,3-diCQA (peak **38**, *t*~R~ 28.07 min) \< 4,5-diCQA (peak **39**, *t*~R~ 28.68 min) \< 3,5-diCQA (peak **40**, *t*~R~ 28.89 min) \< 3,4-diCQA (peak **45**, *t*~R~ 34.01 min). Meanwhile, comparing with the *t*~R~ of CQAs, that of diCQAs was longer significantly. On the other hand, *t*~R~ of C-1 substituted diCQAs was shorter than that of other diCQAs.

Using the above-mentioned rules, the peaks **46** (*m/z* 529.13623 \[M -- H\]^--^), **48** (*m/z* 529.13515 \[M -- H\]^--^), **49** (*m/z* 529.13452 \[M -- H\]^--^) were tentatively deduced. The research process was described as following: in the MS/MS spectra of peaks **46**, **48**, and **49**, there were *m/z* 193.04970 \[M -- H -- C~16~H~16~O~8~\]^--^, 193.04991 \[M -- H -- C~16~H~16~O~8~\]^--^, and 193.04980 \[M -- H -- C~16~H~16~O~8~\]^--^ for **46**, **48**, and **49**, respectively, along with 134.03615 \[M -- H -- C~16~H~16~O~8~ -- CH~3~ -- CO~2~\]^--^, 134.03642 \[M -- H -- C~16~H~16~O~8~ -- CH~3~ -- CO~2~\]^--^, and 134.03607 \[M -- H -- C~16~H~16~O~8~ -- CH~3~ -- CO~2~\]^--^ for **46**, **48**, and **49**, respectively (characteristic fragment ions for feruloyl group); as well as *m/z* 179.03404 \[M -- H − C~17~H~18~O~8~\]^−^, 179.03429 \[M -- H − C~17~H~18~O~8~\]^−^, and 179.03400 \[M -- H − C~17~H~18~O~8~\]^−^, respectively (characteristic fragment ion for caffeoyl group). Therefore, it was presumed that they were CFQAs substituted by a mono-caffeoyl group and a mono-feruloyl group in different positions of quinic acid aglycone at the same time. As the characteristic fragment ion *m/z* 173.04445 was not the base peak ion of their MS/MS spectra, the possibility that caffeoyl or feruloyl linked at C-4 of the quinic acid aglycone was excluded. Combining the chromatographic elution order of diCQAs in the CH~3~CN-H~2~O system summarized above, peaks **46**, **48**, and **49** were deduced to be 1-C-5-FQA/5-C-1-FQA, 1-C-3-FQA/3-C-1-FQA, and 3-C-5-FQA/5-C-3-FQA, respectively. Moreover, in the dominant conformation of the six-membered ring quinic acid aglycone, both 1- and 5-OH were at the axial bond, the substitution on C-1 and 5 were more likely to cleavage from the aglycone in the mass spectrometry than they were at other positions. Thus according to the stability of fragment ions (relative abundance) after substituent cleavage, the substitution position could be preliminary identified. For example, in peak **49**, the fragment ion intensity of *m/z* 367.10309 \[M -- H -- C~9~H~6~O~3~\]^--^ (derived from the cleavage of one caffeoyl group 162 Da) was high, which suggested that the caffeoyl group was linked to the C-5 of quinic acid aglycone. Therefore, it was finally determined that the peak **49** was 3-feruloyl-5-caffeoyl-quinic acid. Using a similar method, peak **48** was speculated to be 1-caffeoyl-3-feruloyl-quinic acid ([Figure S15](#app1-molecules-24-02784){ref-type="app"}).

Peaks **51** (*m/z* 529.13409 \[M -- H\]^--^), **55** (*m/z* 529.13403 \[M -- H\]^--^), **61** (*m/z* 529.13367 \[M -- H\]^--^) ([Figure S15](#app1-molecules-24-02784){ref-type="app"}), **66** (*m/z* 543.15027 \[M -- H\]^--^), and **74** (*m/z* 543.15080 \[M -- H\]^--^) ([Figure S16](#app1-molecules-24-02784){ref-type="app"}) were identified as methyl 4,5-dicaffeoylquinate (4,5-diCQM), 3,5-diCQM, 3,4-diCQM, ethyl 4,5-dicaffeoylquinate (3,5-diCQE), and 3,4-diCQE, respectively, by comparing with reference standards isolated from *P. indica*. Their MS/MS fragment patterns were similar to those of CQMs mentioned above. In detail, in the MS/MS spectra of 4,5-diCQM (peak **51**), 3,5-diCQM (peak **55**), and 3,5-diCQE (peak **66**), the base peak ion was *m/z* 161.02306 \[529.13515 -- C~9~H~6~O~3~ -- C~7~H~12~O~6~ -- CH~2~\]^--^, 161.02304 \[529.13515 -- C~9~H~6~O~3~ -- C~7~H~12~O~6~ -- CH~2~\]^--^, and 161.02316 \[543.15080 -- C~9~H~6~O~3~ -- C~7~H~12~O~6~ -- C~2~H~4~\]^--^, respectively. What is more, and the abundance of *m/z* 135.04356 \[529.13515 -- C~9~H~6~O~3~ -- C~7~H~10~O~5~ -- CH~2~ -- CO~2~\]^--^ and 133.02808 \[543.15080 -- C~9~H~6~O~3~ -- C~7~H~12~O~6~ -- C~2~H~4~ -- CO\]^--^ was also strong in the MS/MS spectra of **55** and **66**, respectively. While, *m/z* 135.04364 \[M -- H -- C~9~H~6~O~3~ -- C~7~H~10~O~5~ -- CH~2~ -- CO~2~\]^--^ and 135.04370 \[M -- H -- C~9~H~6~O~3~ -- C~7~H~10~O~5~ -- C~2~H~4~ -- CO~2~\]^--^ was the base peak for the MS/MS spectra of 3,4-diCQM (peak **61**) and 3,4-diCQE (peak **74**), respectively. These indicated when 3- and/or 5-OH of CQMs/CQEs were substituted by caffeoyl; the base peak ion was at *m/z* 135.04406 or 161.02332. On the other hand, their chromatographic elution order (4,5-diCQM (peak **51**, *t*~R~ 37.80 min) \< 3,5-diCQM (peak **55**, *t*~R~ 38.39 min) \< 3,4-diCQM (peak **61**, *t*~R~ 39.49 min); 3,5-diCQE (peak **66**, *t*~R~ 40.16 min) \< 3,4-diCQE (peak **74**, *t*~R~ 41.61 min)) was consistent with that of di-CQAs. As a result, peak **50** (*m/z* 529.13515 \[M -- H\]^--^) was tentatively identified as 1,4-diCQM according to the base peak ions *m/z* 191.05522 \[M -- H -- 2C~9~H~6~O~3~ -- CH~2~\]^--^ and its *t~R~* (peak **50**, 37.55 min). According to the base peak ions *m/z* 161.02313 \[M -- H -- C~9~H~6~O~3~ -- C~2~H~4~ -- C~7~H~12~O~6~\]^--^ and the *t~R~* (peak **62**, 39.59 min) ([Figure S16](#app1-molecules-24-02784){ref-type="app"}), peak **62** (*m/z* 543.15080 \[M -- H\]^--^) was tentatively identified as 1,5-diCQE or 4,5-diCQE.

It was visible from the above derivation processes that CQFAs were confusing with diCQMs as they possessed the same molecular. The key to distinguish them was the presence of characteristic fragment ions at *m/z* 193.04954 and 134.03623 for the feruloyl group, or not \[[@B23-molecules-24-02784]\].

Peaks **47** (*m/z* 677.15277 \[M -- H\]^--^), **53** (*m/z* 677.15070 \[M -- H\]^--^), and **65** (*m/z* 677.15270 \[M -- H\]^--^) ([Figure S17](#app1-molecules-24-02784){ref-type="app"}) were unambiguously identified as 1,3,5-tricaffeoyl quinic acid (1,3,5-triCQA), 1,3,4-triCQA, 3,4,5-triCQA, respectively, by comparing with reference standards obtained from *P. indica*. As we have mentioned above, the quinic acid aglycone could be substituted by multiple acyls at its 1-, 3-, 4-, and 5-hydroxyl, thus the possibilities of triCQAs included 1,3,5-triCQA, 1,3,4-triCQA, 1,4,5-triCQA, and 3,4,5-triCQA. Then, another triCQA (peak **63**) should be deduced to be 1,4,5-triCQA.

Peak **76** (*m/z* 839.18289 \[M -- H\]^--^) ([Figure S18](#app1-molecules-24-02784){ref-type="app"}), was definitely confirmed to be 1,3,4,5-tetracaffeoyl quinic acid (1,3,4,5-tetraCQA) by comparing with reference standards. Peak **92** (*m/z* 867.21393 \[M -- H\]^--^) ([Figure S18](#app1-molecules-24-02784){ref-type="app"}) was tentatively identified as ethyl 1,3,4,5-tetracaffeoyl quinate (1,3,4,5-tetraCQE), because of the lack of feruloyl group characteristic fragment ions as well as the similarity of its MS/MS spectra with that of 1,3,4,5-tetraCQM (peak **76**) ([Figure S18](#app1-molecules-24-02784){ref-type="app"}). What is more, peak **92** was possible to be a new compound.

Peak **91** (*m/z* 691.16684 \[M -- H\]^--^) ([Figure S19](#app1-molecules-24-02784){ref-type="app"}) was definitely identified as methyl 3,4,5-tricaffeoyl quinate (3,4,5-triCQM) by comparing with reference standards. In the MS/MS spectrum of peak **80** (*m/z* 691.16754 \[M -- H\]^--^) ([Figure S19](#app1-molecules-24-02784){ref-type="app"}), feruloyl group characteristic fragment ions *m/z* 193.04954 and 134.03623 were lacking, while *m/z* 179.03 \[M -- H − 2C~9~H~6~O~3~ − C~7~H~10~O~5~ − CH~2~\]^−^ for caffeoyl group was observed, thus it was speculated to be a triCQM. Because of the lack of samples for summary of MS fragment pathway and retention time rules, peak **80** was tentatively deduced to be 1,3,4-triCQM or 1,3,5-triCQM or 1,4,5-triCQM. In addition, owing to the lack of feruloyl group characteristic fragment ions, and its MS/MS spectrum was similar to that of 3,4,5-triCQM (peak **91**), peak **98** (*m/z* 705.18036 \[M -- H\]^--^) ([Figure S19](#app1-molecules-24-02784){ref-type="app"}) was tentatively identified as ethyl 3,4,5-tricaffeoyl quinate (3,4,5-triCQE). Moreover, peak **98** is potentially novel.

Meanwhile using a similar manner mentioned above, the structure types of the remaining 13 acyl-substituted quinic acids and their derivatives were tentatively proposed ([Table 1](#molecules-24-02784-t001){ref-type="table"}).

### 3.2.2. Structural Elucidation of Phenolic Acids {#sec3dot2dot2-molecules-24-02784}

Peaks **5**, **6**, **10**, **13**, **14**, **19**, **23**, **33**, **34**, **52**, **59**, **74**, **81**, **109**, **112**, and **113** were accurately identified by comparison with reference standards ([Table 1](#molecules-24-02784-t001){ref-type="table"}, [Figure S2](#app1-molecules-24-02784){ref-type="app"}).

Peaks **1** and **7** were unambiguously identified as 3,4-dihydroxy benzoic acid and 3,4-dihydroxybenzaldehyde by comparison with reference standards isolated from *P. indica* \[[@B7-molecules-24-02784]\], respectively. [Figure 4](#molecules-24-02784-f004){ref-type="fig"} showed the MS/MS fragmentation pattern of benzoic acid (peak **1**) and benzaldehyde (peak **7**): the alpha bond cleavage of carbonyl was susceptible to occur in benzoic acid and benzaldehyde, and then generated a fragment ion peak at *m/z* 109.02793 and 109.02798 by removing 44 Da and 28 Da, respectively. Thus, the two types of compounds could be distinguished by the mass lost during this process ([Figure S20](#app1-molecules-24-02784){ref-type="app"}). Peak **12** was definitely identified as 3-methoxy-4-hydroxybenzoic acid by comparison with reference standard. Besides the rule mentioned above, it was also prone to remove one methyl radical, resulting in a strong fragment ion peak at *m/z* 152.01041 \[M -- H -- CH~3~\]^--^; at the same time, it could remove one CO~2~ to form a fragment ion peak of *m/z* 123.04406 \[M -- H -- CO~2~\]^--^. Continually, it could remove one CO~2~ or methyl radical to form fragment ion peak of *m/z* 108.02058 \[M -- H -- CH~3~ -- CO~2~\]^--^/\[M -- H -- CO~2~ -- CH~3~\]^--^, respectively ([Figure 4](#molecules-24-02784-f004){ref-type="fig"} and [Figure S20](#app1-molecules-24-02784){ref-type="app"}).

Peak **8** (*m/z* 167.03381 \[M -- H\]^--^) ([Figure S21](#app1-molecules-24-02784){ref-type="app"}), which has the molecular ion C~8~H~7~O~4~^--^ in its MS/MS spectrum, had fragment ion peaks of *m/z* 152.01022 \[M -- H -- CH~3~\]^--^ and 108.02016 \[M -- H -- CH~3~ -- CO~2~\]^--^, suggesting that one methyl radical (15 Da) and CO~2~ (44 Da) were cleaved from the structure. The existence of 3,4-dihydroxybenzoic acid (**1**) in this plant has been proved above, combining the biosynthetic pathway, peak **8** was tentatively presumed to be methyl 3,4-dihydroxybenzoate.

In the MS/MS spectrum of peak **17** (*m/z* 137.02303, C~7~H~5~O~3~^--^) ([Figure S21](#app1-molecules-24-02784){ref-type="app"}), one CO~2~ (44 Da) was cleaved according to the base peak ion of *m/z* 93.03311 \[M -- H -- CO~2~\]^--^. Therefore, it was deduced that there was a carboxyl group directly attached to the benzene ring in the structure. As a result, peak **17** was tentatively speculated to be 2-hydroxybenzoic acid or 3-hydroxybenzoic acid combining with its molecular formula.

### 3.2.3. Structural Elucidation of Thiophenes {#sec3dot2dot3-molecules-24-02784}

As mentioned above, four thiophenes: (3\'\'*R*)-pluthiophenol (peak **99**, *m/z* 231.04743, *t*~R~ 46.82 min), (3\'\'*R*)-pluthiophenol-4\'\'-acetate (peak **105**, *m/z* 273.05813, *t*~R~ 47.94 min), 3\'\'-ethoxyl-(3\'\'*S*)-pluthiophenol (peak **107**, *m/z* 259.07918, *t*~R~ 49.42 min), and 3\'\'-ethoxyl-(3\'\'*S*)-pluthiophenol-4\'\'-acetate (peak **111**, *m/z* 301.08917, *t*~R~ 53.25 min) have been isolated and identified in our lab \[[@B7-molecules-24-02784]\]. When extracting the above ions from PIE2, four pairs of ion peaks were obtained, the four peaks unseparated were presumed to be (3\'\'*S*)-pluthiophenol (peak **106**, *m/z* 231.04743, *t*~R~ 48.73 min), (3\'\'*S*)-pluthiophenol-4\'\'-acetate (peak **110**, *m/z* 273.05813, *t*~R~ 53.13 min), 3\'\'-ethoxyl-(3\'\'*R*)-pluthiophenol (peak **97**, *m/z* 259.07918, *t*~R~ 46.55 min) and 3\'\'-ethoxyl-(3\'\'*R*)-pluthiophenol-4\'\'-acetate (peak **104**, *m/z* 301.08917, *t*~R~ 47.62 min) ([Figure 5](#molecules-24-02784-f005){ref-type="fig"}). In addition, the fragmentation ions of peaks **110** and **97** were similar to those of peaks **105** and **107** ([Table 1](#molecules-24-02784-t001){ref-type="table"}), respectively, which preliminary confirmed the above inference. While the MS/MS fragmentation ions of peaks **104** and **106** have not been detected. Summarizing their chromatographic elution order, it was found that in the CH~3~CN-H~2~O system the *t*~R~ of the thiophenes with the same planar structure was related to the configuration: the *t*~R~ of 3\'\'*R*-thiophene was shorter than that of 3\'\'*S*-thiophene. The four thiophenes peaks **97**, **104**, **106**, and **110** could be tentatively identified due to their peak orders, and all of them were possible new compounds.

### 3.2.4. Structural Elucidation of Other Compounds {#sec3dot2dot4-molecules-24-02784}

In addition, 13 flavonoids ([Figure S4](#app1-molecules-24-02784){ref-type="app"}) and 11 other compounds ([Figure S5](#app1-molecules-24-02784){ref-type="app"}) were unambiguously identified by comparison to reference standards obtained and identified by our lab \[[@B7-molecules-24-02784],[@B8-molecules-24-02784]\] ([Table 1](#molecules-24-02784-t001){ref-type="table"}). At the same time, when taking literatures into consideration, the possible structures of 11 compounds (9 flavonoids and two sesquiterpenes) were tentatively predicted ([Table 1](#molecules-24-02784-t001){ref-type="table"}).

During this process, an interesting phenomenon has been found that when the 1-position carboxyl of quinic acids were methylated, the base peak of the MS/MS spectra of CQMs were not 191.05501 \[quinic acid − H\]^−^ or 173.04445 \[quinic acid -- H − H~2~O\]^−^ any more, they became 161.02332 \[caffeoyl − H~2~O − H\]^−^ or 135.04406 \[caffeoyl − CO~2~ − H\]^−^. We tried to explain the reason as following: when the quinic acid compound was ionized, the protons at the 1-carboxyl were easily lost, forming a negative charge center. When the charge migrated to the binding oxygen atom between the quinic acid nucleus and the substituted caffeoyl group, the cleavage could occur, and *m/z* 191.05501 \[quinic acid − H\]^−^ and 173.04445 \[quinic acid -- H − H~2~O\]^−^ appeared. While when the 1-carboxyl was methylated, the negative charge center will be generated on the hydroxyl group of the substituted caffeoyl group, and after electron transferred, the chemical bond between the substituted caffeoyl group and the quinic acid nucleus would be broken, and a characteristic ion formed by substituted caffeoyl group would strongly occur on the MS/MS spectrum.

4. Conclusion {#sec4-molecules-24-02784}
=============

In summary, a method integrating normal-phase chromatography and reverse-phase chromatography/mass spectrometry analysis was established to accomplish the chemical profiling of PI. According to the retention time (*t~R~*) and the exact mass-to-charge ratio (*m/z*), 114 compounds were identified or tentatively identified. Among them, 67 compounds were unambiguously identified by comparing to the standard references. Meanwhile, the rules of MS/MS fragmentation pattern and chromatographic elution order have been generalized by using the reference standard, 47 compounds were tentatively speculated, and 10 of them (peaks **3**, **9**, **15**, **28**, **92**, **97**, **98**, **104**, **106**, and **110**) are potentially novel. An accurate and comprehensive chemical composition profiling of the aerial part of the *P. indica* was realized, which laid a foundation for the quality evaluation of the plant.

**Sample Availability:** Samples of the compounds **1**, **2**, **4**, **5**--**7**, **10**--**14**, **16**, **19**, **23**, **29**, **31**--**35**, **37**--**40**, **42**--**45**, **47**, **51**--**57**, **59**, **61**, **65**, **66**, **68**, **71**, **73**--**77**, **81**, **83**, **85**, **86**, **89**, **91**, **93**, **94**, **99**--**102**, **105**, **107**, **109**, **111**--**114** are available from the authors.

Supplementary data (the structures of standard references and MS/MS spectrum of the \[M − H\]^−^ ions for all peaks) associated with this article can be found in the online version.

###### 

Click here for additional data file.
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Chloroform

CQA

Caffeoylquinic acid

CQE

Ethyl caffeoylquinic acid

CQM

Methyl caffeoylquinic acid

CoQA

Coumaroyl quinic acid

CFQM

Methyl caffeoyl-ferulyl-quinate

CCFQA

Dicaffeoyl-ferulyl-quinic acid

CCCFQA

Tricaffeoyl-ferulyl-quinic acid

CCFFQA

Dicaffeoyl-diferulyl-quinic acid

diCQA

Dicaffeoylquinic acid

diCQE

Ethyl diCaffeoylquinic acid

diCQM

Methyl dicaffeoylquinic acid

EtOH

Ethanol

FQA

Feruloyl quinic acid

FEMA

Flavor and Extract Manufacturers Association

GRAS

Generally recognized as safe

LC-MS/MS

Liquid chromatograph-mass/mass spectrometry

MeOH

Methanol

OC-MS

Orthogonal chromatography-mass spectrometry

PI

P. indica

70% EtOH extract

PIEs

Silica gel fractionation of 95% EtOH eluate of

P. indica

TQA

3,4,5-Trihydroxycinnamoyl quinic acid

triCQA

Tricaffeoylquinic acid

triCQE

Ethyl tricaffeoyl quinate

triCQM

Methyl tricaffeoylquinic acid

![Base peak chromatograms of *P. indica* 70% EtOH extract on BEHC18 column in negative and positive mode.](molecules-24-02784-g001){#molecules-24-02784-f001}

###### 

Base peak chromatograms of silica gel fractionation of 95% EtOH eluate of *P. indica* on BEHC18 column in negative mode.
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![Proposed fragmentation patterns and characteristic ions of caffeoylquinic acid.](molecules-24-02784-g003){#molecules-24-02784-f003}

![Proposed fragmentation patterns and characteristic ions of 3,4-dihydroxy benzoic acid (**1**), 3,4-dihydroxy benzaldehyde (**7**) and 3-methoxy-4-hydroxy benzoic acid (**12**).](molecules-24-02784-g004){#molecules-24-02784-f004}

![EIC from PIE2 A: EIC of *m/z* 231.04743; B: EIC of *m/z* 273.05813; C: EIC of *m/z* 259.07918; D: EIC of *m/z* 301.08917.](molecules-24-02784-g005){#molecules-24-02784-f005}

molecules-24-02784-t001_Table 1

###### 

The qualitative analysis of compounds **1**--**114** by ESI-Q-Orbitrap mass spectrometry (MS).

  No.       *t*~R~ (min)   Compound                                                                                                Formula               Adduct Ions            Theoretic   Measure     Diff (ppm)   Identification Fragment Ions (*m/z*) (Intensity)
  --------- -------------- ------------------------------------------------------------------------------------------------------- --------------------- ---------------------- ----------- ----------- ------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **1**     3.17           3,4-Dihydroxy benzoic acid \*                                                                           C~7~H~6~O~4~          \[M − H\]^−^           153.01933   153.01914   −1.24        109.02793 (100)
  **2**     3.51           Adenosine \*                                                                                            C~10~H~13~N~5~O~4~    \[M − H\]^−^           266.08948   266.08969   0.79         134.04578 (100)
  **3**     4.26           5-TQA                                                                                                   C~16~H~18~O~10~       \[M − H\]^−^           369.08272   369.08298   0.70         195.02939(16), 191.05483 (100), 133.02803 (82)
  **4**     4.97           5-CQA \*                                                                                                C~16~H~18~O~9~        \[M − H\]^−^           353.08781   353.08826   1.27         191.05497 (100), 179.03378 (54), 135.04367 (62)
  **5**     5.27           2,3-Dihydroxy-1-(4-hydroxy-3-methoxyphenyl)-propan-1-one \*                                             C~10~H~12~O~5~        \[M − H\]^−^           211.06120   211.06069   −2.41        181.04950 (100), 163.03879 (88)
  **6**     5.28           *p*-Hydroxybenzoic acid \*                                                                              C~7~H~6~O~3~          \[M − H\]^−^           137.02442   137.02309   −0.23        93.03307 (100)
  **7**     5.54           3,4-Dihydroxybenzaldehyde \*                                                                            C~7~H~6~O~3~          \[M − H\]^−^           137.02442   137.02413   −2.12        109.02798 (14)
  **8**     6.69           Methyl 3,4-dihydroxybenzoate                                                                            C~8~H~8~O~4~          \[M − H\]^−^           167.03498   167.03418   −4.79        152.01022 (100), 108.02016 (2)
  **9**     7.39           3-TQA                                                                                                   C~16~H~18~O~10~       \[M − H\]^−^           369.08272   369.08316   −1.19        195.02869 (60), 133.02803 (100)
  **10**    8.13           3,4-Dihydroxy-5-methoxybenzaldehyde \*                                                                  C~8~H~8~O~4~          \[M − H\]^−^           167.03498   167.03424   −4.43        152.01013 (100), 124.01488 (3)
  **11**    8.20           3-CQA \*                                                                                                C~16~H~18~O~9~        \[M − H\]^−^           353.08781   353.08820   1.10         191.05495 (100), 179.03383 (1), 135.04362 (1)
  **12**    8.41           3-Methoxy-4-hydroxybenzoic acid \*                                                                      C~8~H~8~O~4~          \[M − H\]^−^           167.03498   167.03430   −4.07        152.01022 (100), 123.04363 (8), 108.02016 (21)
  **13**    9.30           Esculetin \*                                                                                            C~9~H~6~O~4~          \[M − H\]^−^           177.01933   177.01863   −3.95        141.8685 (72), 133.02802 (100)
  **14**    9.41           Caffiec acid \*                                                                                         C~9~H~8~O~4~          \[M − H\]^−^           179.03498   179.03427   −3.97        135.04359 (100)
  **15**    10.26          4-TQA                                                                                                   C~16~H~18~O~10~       \[M − H\]^−^           369.08272   369.08322   1.35         195.02857 (11), 173.04421 (100)
  **16**    10.69          4-CQA \*                                                                                                C~16~H~18~O~9~        \[M − H\]^−^           353.08781   353.08762   −0.54        191.05493 (49), 179.03373 (66), 173.04429 (100), 135.04366 (72)
  **17**    12.03          2-Hydroxybenzoic acid or 3-Hydroxybenzoic acid                                                          C~7~H~6~O~3~          \[M − H\]^−^           137.02442   137.02413   −2.12        93.03311 (100)
  **18**    14.27          3-CoQA                                                                                                  C~16~H~18~O~8~        \[M − H\]^−^           337.09289   337.09384   2.82         191.05482 (100), 163.03868 (9)
  **19**    17.63          Vanillin \*                                                                                             C~8~H~8~O~3~          \[M − H\]^−^           151.04007   151.03996   −0.73        136.01509 (100), 109.02799 (7)
  **20**    18.44          4-CoQA                                                                                                  C~16~H~18~O~8~        \[M − H\]^−^           337.09289   337.09351   1.84         173.04419 (100), 163.03868 (19)
  **21**    19.61          5-FQA                                                                                                   C~17~H~20~O~9~        \[M − H\]^−^           367.10346   367.10382   0.98         193.04926 (1), 161.02310 (100)
  **22**    19.94          3-FQA                                                                                                   C~17~H~20~O~9~        \[M − H\]^−^           367.10346   367.10373   0.74         193.04933 (7), 191.05495 (100)
  **23**    20.82          Syringicaldehyde \*                                                                                     C~9~H~10~O~4~         \[M − H\]^−^           181.05063   181.05087   1.59         166.02563 (100), 151.00235 (86)
  **24**    21.24          4-FQA                                                                                                   C~17~H~20~O~9~        \[M − H\]^−^           367.10346   367.10376   0.82         193.04939 (17), 173.04428 (100)
  **25**    21.28          Monosulfonyl substituted flavone                                                                        C~15~H~10~O~10~S      \[M − H\]^−^           380.99219   380.99155   1.68         301.03424 (100), 178.99715 (2), 151.00209 (10)
  **26**    21.73          Monosulfonyl substituted flavone                                                                        C~15~H~10~O~10~S      \[M − H\]^−^           380.99219   380.99167   −1.36        301.03586 (100), 178.99789 (25), 151.00278 (65)
  **27**    21.80          Disulfonyl substituted flavone                                                                          C~15~H~10~O~13~S~2~   \[M − H\]^−^           460.94900   460.94988   1.91         380.99248 (75), 301.03577 (100), 178.99805 (19), 151.00278 (40), 96.95886 (18)
  **28**    22.29          5-CQM                                                                                                   C~17~H~20~O~9~        \[M − H\]^−^           367.10346   367.10373   0.74         179.03380 (7), 173.04451 (1), 161.02313 (100), 133.02809 (28)
  **29**    23.12          3-CQM \*                                                                                                C~17~H~20~O~9~        \[M − H\]^−^           367.10346   367.10379   0.90         179.03371 (55), 161.02318 (26), 135.04358 (100)
  **30**    23.73          Monosulfonyl substituted flavone                                                                        C~15~H~10~O~10~S      \[M − H\]^−^           380.99219   380.99255   0.94         301.03479 (100), 178.99739 (21), 151.00240 (53)
  **31**    24.73          Quercetin-3-*O*-β-[d]{.smallcaps}-galactopyranoside \*                                                  C~21~H~20~O~12~       \[M + H\]^+^           463.08820   463.08654   −3.58        300.02689 (100), 271.02435 (51), 255.02951 (23), 243.02861 (10)
  **32**    25.48          Quercetin-3-*O*-β-[d]{.smallcaps}-glucopyranoside \*                                                    C~21~H~20~O~12~       \[M + H\]^+^           463.08820   463.08749   −1.53        300.03 (100), 271.02424 (71), 255.02955 (31), 243.02860 (13)
  **33**    26.49          (+)-Isolariciresinol \*                                                                                 C~20~H~24~O~6~        \[M − H\]^−^           359.15001   359.14966   −0.97        ND
  **34**    26.87          *trans*-Ferulic acid \*                                                                                 C~10~H~10~O~4~        \[M − H\]^−^           193.05063   193.05017   −2.38        161.02310 (28), 133.02797 (19)
  **35**    27.11          1,4-DiCQA \*                                                                                            C~25~H~24~O~12~       \[M − H\]^−^           515.11950   515.11865   −1.65        353.08719 (60), 191.05486 (46), 179.03369 (69), 173.04434 (100), 135.04370 (77)
  **36**    27.63          Kaempferol-*O*-galactopyranoside                                                                        C~21~H~20~O~11~       \[M − H\]^−^           447.09328   447.09430   2.28         284.03174 (84), 255.02882 (100), 227.03365 (82)
  **37**    27.99          1,5-DiCQA \*                                                                                            C~25~H~24~O~12~       \[M − H\]^−^           515.11950   515.12067   2.27         353.08688 (17), 191.05472 (100), 179.03371 (5), 161.02297 (5), 135.04356 (6)
  **38**    28.22          1,3-DiCQA \*                                                                                            C~25~H~24~O~12~       \[M − H\]^−^           515.11950   515.11871   −1.53        353.08694 (12), 191.05495 (100), 179.03365 (4), 161.02303 (5), 135.04370 (6)
  **39**    28.68          4,5-DiCQA \*                                                                                            C~25~H~24~O~12~       \[M − H\]^−^           515.11950   515.12006   1.09         353.08713 (59), 191.05493 (53), 179.03375 (84), 173.04420 (100), 161.02312 (37), 155.03355 (14), 135.04362 (85)
  **40**    28.89          3,5-DiCQA \*                                                                                            C~25~H~24~O~12~       \[M − H\]^−^           515.11950   515.11888   −1.20        353.08697 (57), 191.05480 (100), 179.03369 (51), 173.04446 (5), 135.04363 (54)
  **41**    29.23          Monosulfonyl substituted methoxyflavone                                                                 C~16~H~12~O~10~S      \[M − H\]^−^           395.00784   395.00778   −0.15        315.05048 (100), 300.02689 (41), 271.02438 (26), 255.02913 (13), 243.02908 (6)
  **42**    29.63          Kaempferol 3-*O*-β-[d]{.smallcaps}-glucopyranoside \*                                                   C~21~H~20~O~11~       \[M − H\]^−^           447.09328   447.09423   2.12         284.03159 (79), 255.02875 (100), 227.03368 (87)
  **43**    30.39          Cynaroside \*                                                                                           C~21~H~20~O~11~       \[M − H\]^−^           447.09328   447.09406   1.74         ND
  **44**    31.20          5,7,3\',4\'-Tetrahydroxy-3-methoxy flavonol-3\'-*O*-β-[d]{.smallcaps}-glucopyranoside \*                C~22~H~22~O~12~       \[M − H\]^−^           477.10385   477.10520   2.83         ND
  **45**    33.94          3,4-DiCQA \*                                                                                            C~25~H~24~O~12~       \[M − H\]^−^           515.11950   515.12002   1.01         353.08701 (71), 191.05498 (37), 179.03368 (64), 173.04430 (100), 135.04367 (62)
  **46**    36.21          1-C-5-F-QA or 1-F-5-C-QA                                                                                C~26~H~26~O~12~       \[M − H\]^−^           529.13515   529.13550   0.66         367.10258 (21), 353.08741 (22), 349.09223 (20), 335.07694 (25), 193.04936 (93), 179.03373 (66), 173.04420 (83), 161.02299 (42), 155.03351 (39), 135.04369 (68), 134.03582 (100)
  **47**    36.63          1,3,5-TriCQA \*                                                                                         C~34~H~30~O~15~       \[M − H\]^−^           677.15119   677.15155   0.53         515.11898 (5), 497.10879 (10), 353.08703 (50), 335.07655 (13), 191.05478 (100), 179.03362 (70), 173.04419 (11), 161.02305 (23), 135.04358 (64)
  **48**    37.15          1-C-3-FQA                                                                                               C~26~H~26~O~12~       \[M − H\]^−^           529.13515   529.13581   1.25         367.10327 (43), 191.05527 (100), 173.04451 (54), 161.02300 (12), 134.03579 (18)
  **49**    37.30          3-F-5-CQA                                                                                               C~26~H~26~O~12~       \[M − H\]^−^           529.13515   529.13574   1.12         367.10309 (42), 193.04980 (100), 173.04443 (21), 134.03607 (81)
  **50**    37.49          1,4-DiCQM                                                                                               C~26~H~26~O~12~       \[M − H\]^−^           529.13515   529.13416   −1.87        367.10264 (24), 353.08711 (29), 191.05522 (100), 179.03364 (38), 161.02306 (40), 135.04353 (50)
  **51**    37.77          4,5-DiCQM \*                                                                                            C~26~H~26~O~12~       \[M − H\]^−^           529.13515   529.13501   −0.26        367.10242 (15), 179.03372 (4), 161.02308 (100), 133.02805 (28)
  **52**    37.91          Ethyl caffeate \*                                                                                       C~11~H~12~O~4~        \[M − H\]^−^           207.06628   207.06556   −3.48        179.03377 (27), 159.85886 (41), 135.04372 (44), 127.86897 (35), 103.91862 (14)
  **53**    38.22          1,3,4-TriCQA \*                                                                                         C~34~H~30~O~15~       \[M − H\]^−^           677.15119   677.15070   −0.72        515.11847 (34), 497.10794 (18), 353.08694 (19), 335.07701 (10), 191.05501 (46), 179.03377 (100), 173.04422 (83), 161.02305 (78), 135.04367 (83)
  **54**    38.32          Quercetin \*                                                                                            C~15~H~10~O~7~        \[M − H\]^−^           301.03538   301.03571   1.10         272.02643 (6), 178.99734 (24), 151.00224 (70), 121.02786 (19), 107.01236 (19)
  **55**    38.39          3,5-DiCQM \*                                                                                            C~26~H~26~O~12~       \[M − H\]^−^           529.13515   529.13519   0.08         367.10275 (22), 179.03320 (31), 161.02304 (100), 135.04358 (45)
  **56**    38.45          Triethyl citrate \*                                                                                     C~12~H~20~O~7~        \[M − H\]^−^           275.11362   275.11278   −3.05        ND
  **57**    38.49          Luteolin \*                                                                                             C~15~H~10~O~6~        \[M − H\]^−^           285.04046   285.04114   2.39         151.00223 (10), 133.02827 (32)
  **58**    38.79          CFQM-1                                                                                                  C~27~H~28~O~12~       \[M − H\]^−^           543.15080   543.14954   −2.32        367.10281 (13), 349.09195 (75), 193.04941 (75), 173.04420 (95), 161.02319 (9), 155.03357 (42), 134.03580 (100)
  **59**    39.04          (--)-(7*S*,7\'*S*,8*R*,8\'*R*)-4,4\'-Dihydroxy-3,3\',5,5\'-pentamethoxy-7,9\':7\',9-diepoxylignane \*   C~22~H~26~O~8~        \[M − H\]^−^           415.15748   415.15757   0.22         ND
  **60**    39.39          CFQM-2                                                                                                  C~27~H~28~O~12~       \[M − H\]^−^           543.15080   543.15009   −1.31        367.10251 (25), 349.09210 (18), 193.04941 (100), 161.02301 (49), 134.03583 (18)
  **61**    39.49          3,4-DiCQM \*                                                                                            C~26~H~26~O~12~       \[M − H\]^−^           529.13515   529.13562   0.89         367.10202 (17), 179.03372 (69), 161.02311 (63), 135.04359 (100)
  **62**    39.59          1,5-DiCQE/4,5-DiCQE                                                                                     C~27~H~28~O~12~       \[M − H\]^−^           543.15080   543.15125   0.83         381.11993 (12), 161.02313 (100), 133.02809 (28)
  **63**    39.85          1,4,5-TriCQA                                                                                            C~34~H~30~O~15~       \[M − H\]^−^           677.15119   677.15173   0.80         515.11743 (15), 353.08701 (55), 191.05486 (43), 179.03371 (89), 173.04424 (100), 161.02301 (33), 135.043 64(80)
  **64**    39.89          Methyl 9-hydroxynonanoate \*                                                                            C~10~H~20~O~3~        \[M − H\]^−^           187.13397   187.13403   0.32         141.12700 (100)
  **65**    40.13          3,4,5-TriCQA \*                                                                                         C~34~H~30~O~15~       \[M − H\]^−^           677.15119   677.15179   0.89         515.11885 (22), 353.08701 (33), 191.05479 (61), 179.03371 (96), 173.04419 (100), 161.02303 (43), 135.04364 (84)
  **66**    40.13          3,5-DiCQE \*                                                                                            C~27~H~28~O~12~       \[M − H\]^−^           543.15080   543.15094   0.26         381.11856 (20), 179.03387 (33), 161.02316 (100), 133.02808 (32)
  **67**    40.33          CFQM-3                                                                                                  C~27~H~28~O~12~       \[M − H\]^−^           543.15080   543.15118   0.70         367.10272 (23), 349.09177 (33), 193.04958 (34), 179.03358 (60), 173.04431 (17), 161.02312 (80), 135.04375 (100), 134.03601 (39), 133.02805 (26)
  **68**    40.34          5,6,4\'-Trihydroxy-3,7-dimethoxyflavone \*                                                              C~17~H~14~O~7~        \[M − H\]^−^           329.06667   329.06669   0.06         314.04276 (100), 299.01917 (94), 271.02429 (33), 243.02908 (13)
  **69**    40.84          CFQM-4                                                                                                  C~27~H~28~O~12~       \[M − H\]^−^           543.15080   543.15088   0.15         193.04944 (13), 161.02306 (100), 134.03596 (20), 133.02803 (34)
  **70**    41.10          TriMethoxyflavone                                                                                       C~18~H~16~O~8~        \[M − H\]^−^           359.07724   359.07785   1.70         344.05280 (97), 329.02954 (100), 314.00613 (7), 301.03461 (12), 286.01123 (27), 258.01624 (16)
  **71**    41.24          Kaempferol \*                                                                                           C~15~H~10~O~6~        \[M−H\]^−^             285.04046   285.03998   −1.68        151.00218 (2)
  **72**    41.39          CFQM-5                                                                                                  C~27~H~28~O~12~       \[M−H\]^−^             543.15080   543.15106   0.48         349.09198 (52), 193.04942 (70), 179.03371 (23), 161.02310 (100), 135.04375 (40), 134.03590 (91), 133.02800 (26)
  **73**    41.61          3,4-DiCQE \*                                                                                            C~27~H~28~O~12~       \[M − H\]^−^           543.15080   543.15094   0.26         381.11804 (16), 161.02304 (75), 179.03371 (68), 135.04361 (100)
  **74**    41.68          *threo*-2,3-Bis(4-hydroxy-3-methoxyphenyl)-3-ethoxypropan-1-ol \*                                       C~19~H~24~O~6~        \[M − H\]^−^           347.15001   347.14891   −3.17        161.02312 (9), 135.04370 (16)
  **75**    41.91          9,12,13-Trihydroxyoctadeca-10(*E*),15(*Z*)-dienoic acid \*                                              C~18~H~32~O~5~        \[M − H\]^−^           327.21770   327.21742   −0.86        229.14348 (16), 211.13269 (27), 171.10144 (23)
  **76**    41.98          1,3,4,5-TetraCQA \*                                                                                     C~43~H~36~O~18~       \[M − H\]^−^           839.18289   839.18365   0.91         659.13635 (6), 515.11799 (20), 353.08657 (10), 335.07645 (8), 191.05495 (41), 179.03377 (100), 173.04430 (73), 161.02301 (61), 135.04375 (91)
  **77**    42.08          Isorhamnetin \*                                                                                         C~16~H~12~O~7~        \[M − H\]^−^           315.05103   315.05127   0.76         300.02676 (88), 271.02344 (6), 164.01016 (7), 151.00218 (22)
  **78**    42.10          CFQM-6                                                                                                  C~27~H~28~O~12~       \[M − H\]^−^           543.15080   543.15131   0.94         349.09146 (16), 193.04938 (50), 161.02304 (100), 135.04370 (20), 134.03587 (77), 133.02797 (34)
  **79**    42.10          1,3,4-CCFQA                                                                                             C~35~H~32~O~15~       \[M − H\]^−^           691.16684   691.16785   1.46         529.13403 (10), 367.10284 (20), 349.09241 (9), 193.04938 (100), 179.03378 (73), 161.02312 (58), 135.04370 (44), 133.02805 (84)
  **80**    42.32          1,3,4-TriCQM                                                                                            C~35~H~32~O~15~       \[M − H\]^−^           691.16684   691.16760   1.10         529.1361 (17), 515.11920 (22), 353.08786 (42), 367.10275 (10), 335.07806 (8), 191.05534 (77), 179.03372 (89), 173.04465 (100), 161.02309 (47), 155.03362 (17), 135.04393 (85)
  **81**    42.55          *erythro*-2,3-Bis(4-hydroxy-3-methoxyphenyl)-3-ethoxypropan-1-ol \*                                     C~19~H~24~O~6~        \[M − H\]^−^           347.15001   347.14891   −3.17        179.03271 (81), 135.04364 (100)
  **82**    42.61          1,4,5-CCFQA                                                                                             C~35~H~32~O~15~       \[M − H\]^−^           691.16684   691.16772   1.27         529.13336 (25), 367.10263 (25), 335.07651 (5), 193.04953 (16), 179.03380 (20), 173.04433 (100), 161.02312 (22), 155.03381 (11), 135.04378 (21), 133.02805 (15)
  **83**    43.13          Pinellic acid \*                                                                                        C~18~H~34~O~5~        \[M − H\]^−^           329.23335   329.23300   −1.06        229.14352 (8), 211.13301 (17), 171.10135 (32)
  **84**    43.58          Trihydroxy-dimethoxyflavone                                                                             C~17~H~14~O~7~        \[M − H\]^−^           329.06667   329.06705   1.15         ND
  **85**    43.87          Caryolane-1,9β-diol \*                                                                                  C~15~H~26~O~2~        \[M − H~2~O + H\]^+^   221.18999   221.18954   −2.03        ND
  **86**    44.19          Chrysosplenol C \*                                                                                      C~18~H~16~O~8~        \[M − H\]^−^           359.07724   359.07773   1.36         344.05292 (94), 329.02963 (100), 286.01129 (71)
  **87**    44.30          Centaureidin \*                                                                                         C~18~H~16~O~8~        \[M − H\]^−^           359.07724   359.07791   1.87         344.05289 (89), 329.02954 (89), 344.05289 (89), 329.02954 (89), 314.00644 (40), 301.03482 (17), 286.01126 (97)
  **88**    44.40          CCCFQA-1                                                                                                C~44~H~38~O~18~       \[M − H\]^−^           853.19854   853.19971   1.37         645.15802 (10), 529.13397 (78), 335.07648 (15), 193.04938 (94), 179.03372 (86), 173.04422 (75), 161.02307 (100), 155.03362 (34), 135.04372 (94)
  **89**    44.46          CCFFQA-1                                                                                                C~45~H~40~O~18~       \[M − H\]^−^           867.21419   867.21277   −1.64        193.04977 (5), 161.02315 (100), 135.04369 (11), 133.02803 (47)
  **90**    44.77          CCCFQA-2                                                                                                C~44~H~38~O~18~       \[M − H\]^−^           853.19854   853.19946   1.08         645.16498 (3), 529.13361 (29), 367.10287 (9), 193.04933 (20), 179.03880 (21), 173.04419 (100), 161.02298 (27), 135.04361 (26)
  **91**    44.93          3,4,5-TriCQM \*                                                                                         C~35~H~32~O~15~       \[M − H\]^−^           691.16684   691.16754   1.01         179.03409 (29), 161.02346 (100), 135.04391 (45), 133.02799 (31)
  **92**    45.68          1,3,4,5-TetraCQE                                                                                        C~45~H~40~O~18~       \[M − H\]^−^           867.21419   867.21356   −0.73        355.08116 (26), 179.03372 (23), 161.02294 (100), 135.04371 (47), 133.02806 (43)
  **93**    45.88          Fraxinellone \*                                                                                         C~14~H~16~O~3~        \[M + H\]^+^           233.11722   233.11784   2.66         215.10712 (100), 187.11209 (92)
  **94**    46.07          valenc-1(10)-ene-8,11-diol \*                                                                           C~15~H~26~O~2~        \[M − H~2~O + H\]^+^   221.18999   221.18974   −1.13        203.17982 (100), 161.13272 (21), 147.11707 (45), 133.10150 (30), 119.08596 (81), 109.10172 (35), 107.08604 (35), 95.08617 (56)
  **95**    46.39          Trihydroxy-dimethoxyflavone                                                                             C~17~H~14~O~7~        \[M − H\]^−^           329.06667   329.06699   0.97         ND
  **96**    46.12          CCFFQA-2                                                                                                C~45~H~40~O~18~       \[M − H\]^−^           867.21419   867.21252   −1.93        161.02298 (44), 135.04358 (17), 133.02797 (15)
  **97**    46.55          3\'\'-Ethoxyl-(3\'\'*R*)-pluthiophenol                                                                  C~15~H~14~O~2~S       \[M + H\]^+^           259.07873   259.07944   2.74         213.03680 (100), 199.02121 (55), 185.04228 (53), 173.00558 (78)
  **98**    46.57          3,4,5-TriCQE                                                                                            C~36~H~34~O~15~       \[M − H\]^−^           705.18249   705.18292   0.61         543.15044 (8), 367.10269 (2), 349.09255 (4), 179.03368 (47), 161.02313 (100), 135.04359 (80)
  **99**    46.82          (3\'\'*R*)-pluthiophenol \*                                                                             C~13~H~10~O~2~S       \[M + H\]^+^           231.04743   231.04755   0.52         213.04740 (36), 200.02346 (17), 199.02358 (53)
  **100**   46.89          Clovane-2α,9β-diol \*                                                                                   C~15~H~26~O~2~        \[M − H~2~O + H\]^+^   221.18999   221.19037   1.72         203.17920 (100), 161.13242 (11), 147.11676 (33), 121.10132 (20), 109.10140 (31), 107.08585 (31), 95.08591 (58)
  **101**   47.08          Casticin \*                                                                                             C~19~H~18~O~8~        \[M − H\]^−^           373.09289   373.09366   2.06         358.06879 (77), 343.04517 (100), 328.02164 (18), 312.99838 (13), 300.02676 (33), 285.00342 (34), 257.00858 (33)
  **102**   47.17          (8*R*,9*R*)-Isocaryolane-8,9-diol \*                                                                    C~15~H~26~O~2~        \[M − H~2~O + H\]^+^   221.18999   221.18962   −1.67        ND
  **103**   47.53          Sesquiterpene                                                                                           C~15~H~26~O~2~        \[M − H~2~O + H\]^+^   221.18999   221.18941   −2.62        ND
  **104**   47.62          3\'\'-Ethoxyl-(3\'\'*R*)-pluthiophenol-4\'\'-acetate                                                    C~17~H~16~O~3~S       \[M + H\]^+^           301.08929   301.08945   0.53         ND
  **105**   47.96          (3\'\'*R*)-Pluthiophenol-4\'\'-acetate \*                                                               C~15~H~12~O~3~S       \[M + H\]^+^           273.05799   273.05813   0.51         231.04753 (40), 213.03694 (76), 184.03423 (100)
  **106**   48.73          (3\'\'*S*)-pluthiophenol                                                                                C~13~H~10~O~2~S       \[M + H\]^+^           231.04743   231.04758   0.65         ND
  **107**   49.42          3\'\'-Ethoxyl-(3\'\'*S*)-pluthiophenol \*                                                               C~15~H~14~O~2~S       \[M + H\]^+^           259.07873   259.07918   1.74         213.03680 (100), 199.02121 (42), 185.04228 (43), 173.00558 (73)
  **108**   49.62          Sesquiterpene                                                                                           C~15~H~26~O~2~        \[M − H~2~O + H\]^+^   221.18999   221.18947   −2.35        ND
  **109**   53.00          Dibutylphthalate \*                                                                                     C~16~H~22~O~4~        \[M − H\]^−^           277.15899   277.15901   0.07         ND
  **110**   53.13          (3\'\'*S*)-Pluthiophenol-4\'\'-acetate                                                                  C~15~H~12~O~3~S       \[M + H\]^+^           273.05799   273.05838   1.43         231.04761 (40), 213.03699 (75), 184.03421 (100)
  **111**   53.28          3\'\'-Ethoxyl-(3\'\'*S*)-pluthiophenol-4\'\'-acetate \*                                                 C~17~H~16~O~3~S       \[M + H\]^+^           301.08929   301.08917   −0.40        213.03697 (100), 185.04243 (45), 184.03429 (48), 173.00571 (8)
  **112**   54.98          *trans*-Coniferyl aldehyde \*                                                                           C~10~H~10~O~3~        \[M + H\]^+^           179.07027   179.07063   2.01         ND
  **113**   55.18          (+)-9\'-isovaleryllariciresinol \*                                                                      C~25~H~32~O~7~        \[M − H\]^−^           443.20753   443.20905   3.43         ND
  **114**   55.94          Stigmasterol \*                                                                                         C~29~H~48~O           \[M − H\]^−^           411.36324   411.36307   −0.41        ND

\* The compounds unambiguously identified with the reference standards comparison; CoQA: coumaroyl quinic acid; CQA: caffeoyl quinic acid; CQE: ethyl caffeoyl quinate; CQM: methyl caffeoyl quinate; CFQM: methyl caffeoyl-ferulyl-quinate; CCFQA: dicaffeoyl-ferulyl-quinic acid; CCCFQA: tricaffeoyl-ferulyl-quinic acid; CCFFQA: dicaffeoyl-diferulyl-quinic acid; FQA: feruloyl quinic acid; TQA: 3,4,5-trihydroxycinnamoyl quinic acid. Although the compounds **33**, **43**, **44**, **56**, **59**, **85**, **102**, **109**, and **112**−**114** were identified by the comparison of *t*~R~ with reference standards, while the contents of them were too low to detect their fragments ions, thus they were stated as ND.
